Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.29
+0.15 (2.10%)
At close: Dec 8, 2025, 4:00 PM EST
7.28
-0.01 (-0.15%)
Pre-market: Dec 9, 2025, 8:45 AM EST
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.9 billion as of December 9, 2025. Its market cap has decreased by -50.04% in one year.
Market Cap
1.90B
Enterprise Value
10.05B
1-Year Change
-50.04%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.90B, a decrease of -77.48%. That is a compound annual growth rate of -27.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 1.90B | -50.68% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |